Physicochemical methods for predicting the biological potency of recombinant follicle stimulating hormone: An International Collaborative Study of Isoelectric Focusing and Capillary Zone Electrophoresis

Biologicals

Volumn 30, Issue 3, 2002, Pages 217-234

  Storring, Patrick L ^a   Gaines Das, Rose E ^a   Mulders, J W M ^b   Halder, Marlies ^c  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b NV ORGANON   (Netherlands)

^c JOINT RESEARCH CENTRE   (Italy)

Author keywords

Biological activity; Capillary zone electrophoresis; Follitropin beta; Isoelectric focusing; Recombinant FSH

Indexed keywords

RECOMBINANT FOLLITROPIN;

ACCURACY; ARTICLE; BIOASSAY; CAPILLARY ZONE ELECTROPHORESIS; DRUG ACTIVITY; DRUG DISCRIMINATION; DRUG POTENCY; INTERMETHOD COMPARISON; ISOELECTRIC FOCUSING; PHYSICAL CHEMISTRY; PREDICTION; PRIORITY JOURNAL;

EID: 0036771448     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.2002.0333     Document Type: Article

References (36)

1. Mulders J.W., Derksen M., Swolfs A., Maris F. Prediction of the in vivo biological activity of human recombinant follicle stimulating hormone using quantitative isoelectric focusing. Biologicals. 25:1997;269-281.
2. Wijn, H, Theunissen, F, Wynia, G, Derksen, M, Mulders, JWM, The use of capillary electrophoresis as a novel approach to define the potency of human recombinant follicle stimulating hormone, Journal of Chromatography.
3. de Leeuw R., Mulders J., Voortman G., Rombout F., Damm J., Kloosterboer L. Structure-function relationship of recombinant follicle stimulating hormone (Puregon). Mol Hum Reprod. 2:1996;361-369.
4. Reichert L.E. Jr. Electrophoretic properties of pituitary gonadotropins as studied by electrofocusing. Endocrinology. 88:1971;1029-1044.
5. Stanton P.G., Robertson D.M., Burgon P.G., Schmauk-White B., Hearn M.T. Isolation and physicochemical characterization of human follicle-stimulating hormone isoforms. Endocrinology. 130:1992;2820-2832.
6. Storring P.L. Assaying glycoprotein hormones - the influence of glycosylation on immunoreactivity. Trends Biotechnol. 10:1992;427-432.
7. Zaidi A.A., Froysa B., Diczfalusy E. Biological and immunological properties of different molecular species of human follicle-stimulating hormone: electrofocusing profiles of eight highly purified preparations. J Endocrinol. 92:1982;195-204.
8. Amoresano A., Siciliano R., Orru S., Napoleoni R., Altarocca V., De Luca E. Structural characterisation of human recombinant glycohormones follitropin, lutropin and choriogonadotropin expressed in Chinese hamster ovary cells. Eur J Biochem. 242:1996;608-618.
9. Baenziger J.U., Green E.D. Pituitary glycoprotein hormone oligosaccharides: structure, synthesis and function of the asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin. Biochim Biophys Acta. 947:1988;287-306.
10. Hard K., Mekking A., Damm J.B., Kamerling J.P., de Boer W., Wijnands R.A. Isolation and structure determination of the intact sialylated N-linked carbohydrate chains of recombinant human follitropin expressed in Chinese hamster ovary cells. Eur J Biochem. 193:1990;263-271.
11. Renwick A.G., Mizouchi T., Kochibe N., Kobata A. The asparagine-linked sugar chains of human follicle-stimulating hormone. J Biochem (Tokyo). 101:1987;1209-1221.
12. Rademacher T.W., Parekh R.B., Dwek R.A. Glycobiology. Annu Rev Biochem. 57:1988;785-838.
13. Chappel S.C., Ulloa-Aguirre A., Coutifaris C. Biosynthesis and secretion of follicle-stimulating hormone. Endocr Rev. 4:1983;179-211.
14. Wide L. Follicle-stimulating hormones in anterior pituitary glands from children and adults differ in relation to sex and age. J Endocrinol. 123:1989;519-529.
15. Chotigeat W., Watanapokasin Y., Mahler S., Gray P.P. Role of environmental conditions on the expression levels, glycoform pattern and levels of sialyltransferase for hFSH produced by recombinant CHO cells. Cytotechnology. 15:1994;217-221.
16. Storring P.L., Zaidi A.A., Mistry Y.G., Lindberg M., Stenning B.E., Diczfalusy E. A comparison of preparations of highly purified human pituitary luteinizing hormone: differences in the luteinizing hormone potencies as determined by in vivo bioassays, in vitro bioassay and immunoassay. Acta Endocrinol (Copenh). 101:1982;339-347.
17. Zaidi A.A., Qazi M.H., Diczfalusy E. Molecular composition of human luteinizing hormone: biological and immunological profiles of highly purified preparations after electrofocusing. J Endocrinol. 94:1982;29-36.
18. Storring P.L., Zaidi A.A., Mistry Y.G., Froysa B., Stenning B.E., Diczfalusy E. A comparison of preparations of highly purified human pituitary follicle-stimulating hormone: differences in the follicle-stimulating hormone potencies as determined by in-vivo bioassay, in-vitro bioassay and immunoassay. J Endocrinol. 91:1981;353-362.
19. Burgon P.G., Robertson D.M., Stanton P.G., Hearn M.T. Immunological activities of highly purified isoforms of human FSH correlate with in vitro bioactivities. J Endocrinol. 139:1993;511-518.
20. D'Antonio M., Borrelli F., Datola A., Bucci R., Mascia M., Polletta P. Biological characterization of recombinant human follicle stimulating hormone isoforms. Hum Reprod. 14:1999;1160-1167.
21. Timossi C.M., Barrios-de-Tomasi J., Gonzalez-Suarez R., Arranz M.C., Padmanabhan V., Conn P.M. Differential effects of the charge variants of human follicle-stimulating hormone. J Endocrinol. 165:2000;193-205.
22. Vitt U.A., Kloosterboer H.J., Rose U.M., Mulders J.W., Kiesel P.S., Bete S. Isoforms of human recombinant follicle-stimulating hormone: comparison of effects on murine follicle development in vitro. Biol Reprod. 59:1998;854-861.
23. Steelman S.L., Pohley F.M. Assay of the follicle-stimulating hormone based on the augmentation with human chorionic gonadotropin. Endocrinology. 53:1953;604-616.
24. European Pharmacopoeia, Strasbourg, Council of Europe, 1997.
25. Garthoff B., Hendriksen C., Bayol A., Goncalves D., Grauer A., de Leeuw R. Safety and efficacy testing of hormones and related products. The Report and Recommendations of ECVAM Workshop 9. ATLA. 23:1995;699-712.
26. Campbell P.J. International biological standards and reference preparations. II. Procedures used for the production of biological standards and reference preparations. J Biol Stand. 2:1974;259-267.
27. WHO Expert Committee on Biological Standardization, Twenty-ninth Report. 1978.
28. Olijve W., de Boer W., Mulders J.W., van Wezenbeek P.M. Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon). Mol Hum Reprod. 2:1996;371-382.
29. Jeffcoate S.L. Standardization of human follicle-stimulating hormone for therapy and diagnosis: report of an International Workshop, National Institute of Biological Standards & Control, UK, 21-22 March 1996. Clin Endocrinol (Oxf). 46:1997;527-529.
30. Mulders J.W.M., Wijn H., Theunissen F., Machielsen P., Janssen P. Prediction of the in-vivo biological activity of human recombinant follicle-stimulating hormone using quantitative isoelectric focusing. Optimization of the model. Pharmacy and Pharmacology Communications. 5:1999;51-55.
31. Watson E., Yao F. Capillary electrophoretic separation of human recombinant erythropoietin (r-HuEPO) glycoforms. Anal Biochem. 210:1993;389-393.
32. Hermentin P., Doenges R., Witzel R., Hokke C.H., Vliegenthart J.F., Kamerling J.P. A strategy for the mapping of N-glycans by high-performance capillary electrophoresis. Anal Biochem. 221:1994;29-41.
33. Palmer C.P., Vandeginste B.G.M. Statistical evaluation of various qualitative parameters in capillary electrophoresis. J Chromatogr A. 718:1995;153-165.
34. Shihabi Z.K., Hinsdale M.E. Some variables affecting reproducibility in capillary electrophoresis. Electrophoresis. 16:1995;159-163.
35. Nickerson B. The determination of a degradation product in clidinium bromide drug substance by capillary electrophoresis with indirect UV detection. J Pharm Biomed Anal. 15:1997;965-971.
36. Curren R.D., Southee J.A., Spielmann H., Liebsch M., Fentem J.H., Balls M. The role of prevalidation in the development, validation and acceptance of alternative methods. ATLA. 23:1995;211-217.